Browsing Centre for Biochemical Pharmacology by Author "Al-Lehebi, R"
Now showing items 1-9 of 9
-
Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry.
Scelo, G; Torres-Duque, CA; Maspero, J; Tran, TN; Murray, R; Martin, N; Menzies-Gow, AN; Hew, M; Peters, MJ; Gibson, PG (2023-08-26)BACKGROUND: Investigation for the presence of asthma comorbidities is recommended by GINA as their presence can complicate asthma management. OBJECTIVE: To understand the prevalence and pattern of comorbidities and ... -
Association between pre-biologic T2-Biomaker combinations and response to biologics in patients with severe asthma
Porsbjerg, CM; Townend, J; Bergeron, C; Christoff, GC; Katsoulotos, GP; Larenas-Linnemann, D; Tran, TN; Al-Lehebi, R; Bosnic-Anticevich, SZ; Busby, J -
Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe Asthma.
Wechsler, ME; Scelo, G; Larenas-Linnemann, DES; Torres-Duque, CA; Maspero, J; Tran, TN; Murray, RB; Martin, N; Menzies-Gow, AN; Hew, M (2023-11-28)RATIONALE: Previous studies investigating comorbidity impact on biologic effectiveness have been relatively small, of short duration, and have not compared biologic classes. OBJECTIVES: To determine the association between ... -
Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in patients with severe asthma eligible for both
Pfeffer, PE; Ali, N; Murray, R; Ulrik., C; Tran, TN; Maspero, J; Peters, M; Christoff, GC; Sadatsafavi, M; Torres-Duque, CA (2023) -
Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in severe asthma patients eligible for both
Price, D; pfeffer, P; Ali, N; Murray, R; Ulrik, C; Tran, T; Maspero, J; Peters, M; Christoff, G; Sadatsafavi, M (2022) -
Exploring definitions and predictors of response to biologics for severe asthma.
Scelo, G; Tran, TN; Le, TT; Faregås, M; Dorscheid, D; Busby, J; Al-Ahmad, M; Al-Lehebi, R; Altraja, A; Beastall, A (Elsevier, 2024-05-19)BACKGROUND: Biologic effectiveness is often assessed as 'response', a term which eludes consistent definition. Identifying those most likely to respond in real-life has proven challenging. OBJECTIVE: To explore definitions ... -
Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry.
Chen, W; Tran, TN; Sadatsafavi, M; Murray, R; Wong, NCB; Ali, N; Ariti, C; Bulathsinhala, L; Gil, EG; FitzGerald, JM (2023-09)BACKGROUND: Effectiveness of biologics has neither been established in patients with high oral corticosteroid exposure (HOCS) nor been compared with effectiveness of continuing with HOCS alone. OBJECTIVE: To examine the ... -
Real-life biomarker response to anti-IL5 and anti-IgE therapies in severe asthma patients
Burkill, S; Porsbjerg, CM; Bourdin, A; Tran, TN; Martin, N; Katial, R; Barker, P; Wechsler, ME; Maspero, J; Bosnic-Anticevich, S (2022) -
Reply to "Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry".
Chen, W; Tran, TN; Sadatsafavi, M; Murray, RB; Boon Wong, NC; Ali, N; Ariti, C; Bulathsinhala, L; Garcia Gil, E; FitzGerald, JM (2024-02)